pyrrolidine dithiocarbamate has been researched along with Mesenteric Vascular Occlusion in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aytekin, FO; Bir, F; Erdem, E; Kabay, B; Ozden, A; Sacar, M; Teke, Z; Yenisey, C | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and Mesenteric Vascular Occlusion
| Article | Year |
|---|---|
Pyrrolidine dithiocarbamate reduces lung injury caused by mesenteric ischemia/reperfusion in a rat model.
Topics: Animals; Antioxidants; Capillary Permeability; Disease Models, Animal; Glutathione; Lung; Malondialdehyde; Mesenteric Vascular Occlusion; Neutrophil Activation; Neutrophils; Nitrates; Nitrites; Pulmonary Edema; Pyrrolidines; Random Allocation; Rats; Rats, Wistar; Reperfusion Injury; Thiocarbamates | 2007 |